GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Xebra Brands Ltd (XCNQ:XBRA) » Definitions » Debt-to-Asset

Xebra Brands (XCNQ:XBRA) Debt-to-Asset : 0.00 (As of Nov. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Xebra Brands Debt-to-Asset?

Xebra Brands's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Nov. 2023 was C$0.00 Mil. Xebra Brands's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Nov. 2023 was C$0.00 Mil. Xebra Brands's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Nov. 2023 was C$1.29 Mil. Xebra Brands's debt to asset for the quarter that ended in Nov. 2023 was 0.00.


Xebra Brands Debt-to-Asset Historical Data

The historical data trend for Xebra Brands's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xebra Brands Debt-to-Asset Chart

Xebra Brands Annual Data
Trend Feb20 Feb21 Feb22 Feb23
Debt-to-Asset
0.06 0.02 0.01 -

Xebra Brands Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Xebra Brands's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Xebra Brands's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xebra Brands's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Xebra Brands's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Xebra Brands's Debt-to-Asset falls into.



Xebra Brands Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Xebra Brands's Debt-to-Asset for the fiscal year that ended in Feb. 2023 is calculated as

Xebra Brands's Debt-to-Asset for the quarter that ended in Nov. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Xebra Brands  (XCNQ:XBRA) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Xebra Brands Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Xebra Brands's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Xebra Brands (XCNQ:XBRA) Business Description

Traded in Other Exchanges
Address
1090 Hamilton Street, Vancouver, BC, CAN, V6B 2R9
Xebra Brands Ltd is focused on cannabis cultivation and products, with global brands and intellectual property. Its products cover wellness and leisure and include beverages. It has one reportable business segment, being the cultivation, processing, manufacturing, design and delivery of cannabis products.

Xebra Brands (XCNQ:XBRA) Headlines

No Headlines